same healthy individuals. It should be noted that the MBC layer harvested from the Ficoll-Paque gradient separation has considerable platelet contamination which is not completely removed by washing with phosphate buffer solution. Consequently, ignoring the contribution of these contaminating platelets can lead to an over-estimation of MBC magnesium content of up to 750/0. This will obviously contribute to the variation noted by the authors.
Many studies in the literature have utilized the Ficoll-Paque gradient separation technique to calculate MBC magnesium content. However, to date, the platelet contamination factor has been ignored. This may partially explain contradictory results that have been published. We are currently assessing this situation in greater detail. However, it must be clearly emphasized to all research workers assessing white cell magnesium content by using the Ficoll-Paque gradient that the omission of the platelet contamination in the mononuclear cell layer will lead to spurious results. 
Authors' reply
Dr Kemp and his colleagues are correct in stating that MBC magnesium content measured as fmoll cell was higher in ill patients than the healthy community controls in our study, P=0·028. When measured as JLmollmg protein however, MBC magnesium was lower in the same ill patients than in the same healthy controls, P<O·OO1. While both results are statistically significant only the latter could be said to be highly significant. We agree that illness affects the characteristics of the MBC cells and could lead to spurious conclusions about magnesium status. Our principal conclusion was 'observed alterations in magnesium MBC content or concentration during illness could reflect to a far greater extent the effects of illness on cell characteristics compared with the effects on (body) magnesium status per se' . Ann Clin Biochem 1993: 30 As regards platelet contamination we stated that 'it is possible that such factors as residual platelet contamination, despite repeated washings with phosphate buffer to remove platelets, have contributed to the analytical error'. We are therefore aware of the problem caused by the contribution of platelet contamination of the MBC layer and we are pleased that this problem is being addressed in greater detail by Dr Kemp and his colleagues.
Serum creatinine: effect of delay in separation
We have read with interest the findings of Simpson I regarding the effect on serum creatinine measurement of delayed separation of blood samples and have performed a similar study. Three millilitres of blood was collected from 26 patients including some with renal impairment and dispensed into each of four 10 mL tubes without anticoagulant (LIP Ltd, Shipley, UK) and stored at room temperature. Serum was separated following centrifugation at 2, 24, 48 and 72 h (one aliquot from each of the four original blood tubes), and stored at 4°C until analysis.
Creatinine was measured in duplicate by a kinetic Jaffe procedure on a Hitachi 717 analyser (BM UK Ltd, Lewes, UK) using BM reagents. All sera from a single patient were analysed in the same batch. Basal creatinine levels (2 h sample) ranged from 88 to 1188JLmollL. Intra batch precision was assessed at three levels using pooled human serum. Coefficients of variation were 1'2%, 1'3% and 0'70/0 at 87, 326 and 500 JLmollL, respectively.
There was a significant difference (P<O'OOI) between the serum creatinine concentrations at 2 and 24 h, 24 and 48 h, but not between 48 and 72 h. The differences between the levels at 2 and 72 h are shown in Fig. 1 . There is a weak inverse correlation between the increase in creatinine on delayed separation and the basal level (Spearman's rank correlation = -O' 39, P=0·05). Harrison-has suggested that the apparent increase in creatinine is due to pyruvate which is known to interfere with the Jaffe reaction.' We have added pyruvate to pooled normal serum at levels of 600, 1000 and 1600 /olmol/L, similar to those which would be expected in serum when there have been delays of 48 to 72 h before separation," and found increases in measured creatinine of 7, 12 and 20/olmo1/L, respectively. These increases are similar to those indicated in Fig. 1 for most patients with a serum creatinine level < 800 /olmol/L adding further weight to the argument that pyruvate is indeed the interfering substance.
The increase in measured creatinine which was observed to occur with delayed separation of serum is much less in this study than that reported by Simpson but may be of clinical significance, particularly at normal levels. The effect of interfering chromogens such as pyruvate may vary with reaction conditions such as reagent and surfactant concentration, temperature, wavelength and measurement time. We therefore recommend that laboratories using the Jaffe procedure perform similar studies before accepting old samples for creatinine assay. The emergence of microalbuminuria as a powerful, largely independent, risk factor for large and small vessel disease in diabetes makes the report of West et at,' on prevalence of microalbuminuria, its association with vascular complications and the ethnic variation in these, of interest and importance.
The pooling of IDDM and NIDDM patients in this report makes interpretation difficult since mechanisms of microalbuminuria and its implications may well differ, perhaps from race to race. It might have been more appropriate to have analysed only the NIDDM patients (770/0 of the sample) rather than create heterogeneity within each ethnic group.
The variable practice of 'screening out' clinical proteinuria with prior Albustix testing introduces another uncertainty. We found, many years ago.? that almost one-third of Albustix-positive urines had less than 200 /olg/mL of albumin on immunoassay (and half of these were below 30/olg/mL). In a more recent study! precisely one-third of urine samples in the micro albuminuric range (20-200 /olg/min), all with albumin concentrations between 30 and 208 /olg/mL, gave an Albustix-positive result (trace-positive results were ignored). Excluding Albustix-positives may thus remove many true albuminurics and reduce prevalence estimates.
It was of interest that West et al. found a significant excess of peripheral and cerebrovascular disease but not of ischaemic heart disease (IHD) in microalbuminuric diabetic patients compared to normoalbuminuric patients. In assessing IHD much depends on methodology, in particular whether standard ECGs are systematically included and classified by the Minnesota Code. In assessing the association of vascular outcomes with urinary albumin excretion, it is important to take 'confounding variables' such as arterial blood pressure, serum lipids and smoking into account, both within and between ethnic groups.
